AI assistant
AtriCure, Inc. — Director's Dealing 2015
Dec 7, 2015
31802_dirs_2015-12-07_c2bdaeb1-13f5-4a0c-afde-9718327e6870.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2015-12-03
Reporting Person: Seith Douglas J (Chief Operating Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-12-03 | Common Stock | M | 5000 | $11.06 | Acquired | 130215 | Direct |
| 2015-12-03 | Common Stock | S | 5000 | $21.55 | Disposed | 125215 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-12-03 | Stock Option (right to buy) | $11.06 | M | 5000 | Disposed | 2016-02-08 | Common Stock (5000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 3500 | Indirect |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $21.54 to $21.57 per share. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2: The Reporting Person disclaims beneficial ownership of these securities, except as to his pecuniary interest therein.
F3: These options were granted on February 8, 2006 and are exercisable as to 25% of the shares one year from the date of grant, and the remaining 75% thereafter vests and is exercisable in equal monthly installments on the same day of the month over the following three years.